Company news

NATCO Pharma Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Press Release Feb 04 2023

February 4, 2023

Press Release Dec 05 2022

December 5, 2022

Press Release Nov 16 2022

November 16, 2022

Press Release Nov 12 2022

November 12, 2022

Press Release Nov 09 2022

November 9, 2022

Press Release Oct 21 2022

October 21, 2022

Press Release Oct 04 2022

October 4, 2022

Press Release Sep 24 2022

September 24, 2022

Press Release Sep 19 2022

September 19, 2022

Press Release Aug 17 2022

August 17, 2022

NATCO records INR 918.9 Crore consolidated revenue and INR 320.4 Crore of profit, after tax, for the First Quarter, FY2022-23

August 10, 2022

Press Release Jul 25 2022

July 25, 2022

NATCO Announces Launch of First Generic Version of Nexavar (Sorafenib) Tablets in the U.S. Market

June 2, 2022

Press Release Jun 01 2022

June 1, 2022

NATCO records INR 2043.8 Crore consolidated revenue and INR 170.0 Crore of profit, after tax, for the year ended March 31' 2022

May 31, 2022

NATCO Announces Launch of the First Generic Version of Revlimid (Lenalidomide capsules), in the U.S. market

March 8, 2022

Press Release Mar 07 2022

March 7, 2022

NATCO announces License Agreement with the Medicines Patent Pool

January 21, 2022

Press Release Jan 20 2022

January 20, 2022

Press Release Jan 07 2022

January 7, 2022

Press Release Jan 01 2022

January 1, 2022

NATCO Pharma receives approval for Molnupiravir Capsules 200 mg for the treatment of Covid-19 in India

December 29, 2021

Press Release Dec 28 2021

December 28, 2021

Press Release Nov 18 2021

November 18, 2021

Natco Pharma launches Everolimus tablets 10 mg in US market

October 4, 2021

Press Release Oct 01 2021

October 1, 2021

Press Release Sep 02 2021

September 2, 2021

Press Release Aug 20 2021

August 20, 2021

Press Release Aug 03 2021

August 3, 2021

Press Release Jul 07 2021

July 7, 2021

Press Release Jun 14 2021

June 14, 2021

Press Release May 22 2021

May 22, 2021

Press Release May 21 2021

May 21, 2021

Press Release May 17 2021

May 17, 2021

Press Release May 03 2021

May 3, 2021

Press Release Apr 26 2021

April 26, 2021

NATCO Pharma receives tentative approval for Ibrutinib tablets (generic for IMBRUVICA) ANDA in the US market

April 13, 2021

Press Release Apr 10 2021

April 10, 2021

NATCO Pharma forays into Pheromone based technology for Integrated Pest Management

March 16, 2021

Press Release Mar 15 2021

March 15, 2021

Press Release Mar 08 2021

March 8, 2021

NATCO Pharma launches Brivaracetam tablets, in India, for treatment of epilepsy

March 1, 2021

Press Release Feb 26 2021

February 26, 2021

NATCO Pharma receives approval for Chlorantraniliprole 1st key product of Crop Health Sciences Division

February 8, 2021

Press Release Feb 05 2021

February 5, 2021

NATCO Pharma launches anti blood clot tablet Rivaroxaban in India

December 18, 2020

Press Release Dec 17 2020

December 17, 2020

NATCO Pharma receives Pomalidomide approval for US market

November 16, 2020

Press Release Nov 13 2020

November 13, 2020

Press Release Nov 12 2020

November 12, 2020

← Newer news releases · Older news releases →

Decks

The 5 newest of 63 decks. Every deck is listed under its year.